Literature DB >> 3219986

[Supraclavicular lymph node metastasis from carcinoma of the uterine cervix after radiotherapy--analysis of 219 patients].

Z H Yao1, A R Wu.   

Abstract

From Mar. 1958 to Dec. 1985, 13547 patients with cervical cancer in stages I-III were treated by radiotherapy in our hospital. Supraclavicular lymph node metastasis developed in 219 (1.62%), 83.1% on the left, 7.7% on the right and 9.13% bilateral. 61.2% of the metastasis occurred within 2 years and 86.75% within 5 years after radiotherapy. The majority of these patients (88.3%, 191/215), except 4 who are still being followed, had died within 1.5 years of metastasis with a mean survival of 9.3 months. If radiotherapy in adequate dose is given to the supraclavicular metastatic area, the mean survival can be prolonged for 3.7 months. The prognosis is very poor for these patients no matter what the clinical stage is or when the metastasis develops. The more advanced clinical stage, the higher metastasis rate (P less than 0.001). In this series, 47/219 (21.5%) were found to have concurrent metastasis to the other organs.

Entities:  

Mesh:

Year:  1988        PMID: 3219986

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  4 in total

1.  Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement.

Authors:  Seok Ho Lee; Seung Heon Lee; Kyu Chan Lee; Kwang Beom Lee; Jin Woo Shin; Chan Yong Park; Sun Jin Sym; Jun-Ho Lee
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

2.  Management of MRI-Detected Benign Internal Mammary Lymph Nodes.

Authors:  Gozde Gunes; Priscila Crivellaro; Derek Muradali
Journal:  Indian J Radiol Imaging       Date:  2022-07-13

Review 3.  Ultrasound of malignant cervical lymph nodes.

Authors:  A T Ahuja; M Ying; S Y Ho; G Antonio; Y P Lee; A D King; K T Wong
Journal:  Cancer Imaging       Date:  2008-03-25       Impact factor: 3.909

Review 4.  Review of ultrasonography of malignant neck nodes: greyscale, Doppler, contrast enhancement and elastography.

Authors:  M Ying; K S S Bhatia; Y P Lee; H Y Yuen; A T Ahuja
Journal:  Cancer Imaging       Date:  2014-01-06       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.